ReviewFrontiers in immunology2025
Engineered cell therapies for autoimmune diseases: evaluating CAR-T and CAR-M progress and prospects.
Mingxuan Zheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it